1-10 of 10
Victoria M. Richon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CCR 20th Anniversary Commentary: Vorinostat—Gateway to Epigenetic Therapy

Wm. Kevin Kelly, Paul Marks, Victoria M. Richon
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (10): 2198–2200.
https://doi.org/10.1158/1078-0432.CCR-14-2556
Published: 14 May 2015
View articletitled, CCR 20th Anniversary Commentary: Vorinostat—Gateway to Epigenetic Therapy
Open the PDF for CCR 20th Anniversary Commentary: Vorinostat—Gateway to Epigenetic Therapy in another window
Journal Articles

Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks

Diane Palmieri, Paul R. Lockman, Fancy C. Thomas, Emily Hua, Jeanne Herring, Elizabeth Hargrave, Matthew Johnson, Natasha Flores, Yongzhen Qian, Eleazar Vega-Valle, Kunal S. Taskar, Vinay Rudraraju, Rajendar K. Mittapalli, Julie A. Gaasch, Kaci A. Bohn, Helen R. Thorsheim, David J. Liewehr, Sean Davis, John F. Reilly, Robert Walker, Julie L. Bronder, Lionel Feigenbaum, Seth M. Steinberg, Kevin Camphausen, Paul S. Meltzer, Victoria M. Richon, Quentin R. Smith, Patricia S. Steeg
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6148–6157.
https://doi.org/10.1158/1078-0432.CCR-09-1039
Published: 30 September 2009
View articletitled, Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
Open the PDF for Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks in another window
Includes: Supplementary data
Journal Articles

Control of Cell Growth and Survival by Enzymes of the Fatty Acid Synthesis Pathway in HCT-116 Colon Cancer Cells

Yanai Zhan, Nicole Ginanni, Michael R. Tota, Margaret Wu, Nathan W. Bays, Victoria M. Richon, Nancy E. Kohl, Eric S. Bachman, Peter R. Strack, Stefan Krauss
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (18): 5735–5742.
https://doi.org/10.1158/1078-0432.CCR-07-5074
Published: 14 September 2008
View articletitled, Control of Cell Growth and Survival by Enzymes of the Fatty Acid Synthesis Pathway in HCT-116 Colon Cancer Cells
Open the PDF for Control of Cell Growth and Survival by Enzymes of the Fatty Acid Synthesis Pathway in HCT-116 Colon Cancer Cells in another window
Journal Articles

Mechanisms of Resistance to Histone Deacetylase Inhibitors and Their Therapeutic Implications

Valeria R. Fantin, Victoria M. Richon
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (24): 7237–7242.
https://doi.org/10.1158/1078-0432.CCR-07-2114
Published: 19 December 2007
View articletitled, Mechanisms of Resistance to Histone Deacetylase Inhibitors and Their Therapeutic Implications
Open the PDF for Mechanisms of Resistance to Histone Deacetylase Inhibitors and Their Therapeutic Implications in another window
Journal Articles

Novel Histone Deacetylase Inhibitors in the Treatment of Thyroid Cancer

Constantine S. Mitsiades, Vassiliki Poulaki, Ciaran McMullan, Joseph Negri, Galinos Fanourakis, Athina Goudopoulou, Victoria M. Richon, Paul A. Marks, Nicholas Mitsiades
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (10): 3958–3965.
https://doi.org/10.1158/1078-0432.CCR-03-0776
Published: 16 May 2005
View articletitled, Novel Histone Deacetylase Inhibitors in the Treatment of Thyroid Cancer
Open the PDF for Novel Histone Deacetylase Inhibitors in the Treatment of Thyroid Cancer in another window
Journal Articles

Histone Deacetylase Inhibitors Induce Growth Suppression and Cell Death in Human Rhabdomyosarcoma in Vitro

Martha C. Kutko, Richard D. Glick, Lisa M. Butler, Dennis C. Coffey, Richard A. Rifkind, Paul A. Marks, Victoria M. Richon, Michael P. LaQuaglia
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (15): 5749–5755.
Published: 03 December 2003
View articletitled, Histone Deacetylase Inhibitors Induce Growth Suppression and Cell Death in Human Rhabdomyosarcoma in Vitro
Open the PDF for Histone Deacetylase Inhibitors Induce Growth Suppression and Cell Death in Human Rhabdomyosarcoma in Vitro in another window
Journal Articles

Phase I Clinical Trial of Histone Deacetylase Inhibitor: Suberoylanilide Hydroxamic Acid Administered Intravenously

Wm. Kevin Kelly, Victoria M. Richon, Owen O’Connor, Tracy Curley, Barbara MacGregor-Curtelli, William Tong, Mark Klang, Lawrence Schwartz, Stacie Richardson, Eddie Rosa, Marija Drobnjak, Carlos Cordon-Cordo, Judy H. Chiao, Richard Rifkind, Paul A. Marks, Howard Scher
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3578–3588.
Published: 23 September 2003
View articletitled, Phase I Clinical Trial of Histone Deacetylase Inhibitor: Suberoylanilide Hydroxamic Acid Administered Intravenously
Open the PDF for Phase I Clinical Trial of Histone Deacetylase Inhibitor: Suberoylanilide Hydroxamic Acid Administered Intravenously in another window
Journal Articles

Histone Deacetylase Inhibitors: A New Class of Potential Therapeutic Agents for Cancer Treatment: Commentary re: V. Sandor et al. , Phase I Trial of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228, NSC 630176), in Patients with Refractory Neoplasms. Clin. Cancer Res., 8: 718–728, 2002.

Victoria M. Richon, James P. O’Brien
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (3): 662–664.
Published: 01 March 2002
View articletitled, Histone Deacetylase Inhibitors: A New Class of Potential Therapeutic Agents for Cancer Treatment: Commentary re: V. Sandor et al. , Phase I Trial of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228, NSC 630176), in Patients with Refractory Neoplasms. Clin. Cancer Res., 8: 718–728, 2002.
Open the PDF for Histone Deacetylase Inhibitors: A New Class of Potential Therapeutic Agents for Cancer Treatment: Commentary re: V. Sandor et al. , Phase I Trial of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228, NSC 630176), in Patients with Refractory Neoplasms. Clin. Cancer Res., 8: 718–728, 2002. in another window
Journal Articles

Inhibitors of Histone Deacetylase Are Potentially Effective Anticancer Agents

Paul A. Marks, Richard A. Rifkind, Victoria M. Richon, Ronald Breslow
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (4): 759–760.
Published: 01 April 2001
View articletitled, Inhibitors of Histone Deacetylase Are Potentially Effective Anticancer Agents
Open the PDF for Inhibitors of Histone Deacetylase Are Potentially Effective Anticancer Agents in another window
Journal Articles

Inhibition of Transformed Cell Growth and Induction of Cellular Differentiation by Pyroxamide, an Inhibitor of Histone Deacetylase

Lisa M. Butler, Yael Webb, David B. Agus, Brian Higgins, Thomas R. Tolentino, Martha C. Kutko, Michael P. LaQuaglia, Marija Drobnjak, Carlos Cordon-Cardo, Howard I. Scher, Ronald Breslow, Victoria M. Richon, Richard A. Rifkind, Paul A. Marks
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (4): 962–970.
Published: 01 April 2001
View articletitled, Inhibition of Transformed Cell Growth and Induction of Cellular Differentiation by Pyroxamide, an Inhibitor of Histone Deacetylase
Open the PDF for Inhibition of Transformed Cell Growth and Induction of Cellular Differentiation by Pyroxamide, an Inhibitor of Histone Deacetylase in another window